Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Melanoma × Radiotherapy × Clear all

Phase

Status

Completed 13 Terminated 6 Withdrawn 5 Active not recruiting 5 Recruiting 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 26 Carcinoma, Non-Small-Cell Lung 19 Breast Neoplasms 18 Rectal Neoplasms 15 Neoplasms 15 Squamous Cell Carcinoma of Head and Neck 14 Glioblastoma 14 Esophageal Squamous Cell Carcinoma 14 Lung Neoplasms 13 Head and Neck Neoplasms 11 Esophageal Neoplasms 11 Uterine Cervical Neoplasms 8 Nasopharyngeal Carcinoma 8 Glioma 8 Radiation Injuries 7 Oropharyngeal Neoplasms 7 Stomach Neoplasms 6 Small Cell Lung Carcinoma 6 Neoplasm Metastasis 6 Pancreatic Neoplasms 5 Oligodendroglioma 5 Hyperthermia 5 Carcinoma, Hepatocellular 5 Brain Neoplasms 5 Urinary Bladder Neoplasms 4 Sarcoma 4 Colorectal Neoplasms 4 Astrocytoma 4 Advanced NSCLC 4 NSCLC 3

Interventions

Nivolumab 47 pembrolizumab 46 Ipilimumab 26 Cyclophosphamide 13 Specimen Handling 10 Radiosurgery 10 Magnetic Resonance Spectroscopy 10 Opdualag 9 fludarabine 8 Biopsy 8 relatlimab 7 binimetinib 7 Blood Specimen Collection 7 aldesleukin 6 Interleukin-2 6 encorafenib 5 cemiplimab 5 Paclitaxel 5 Bevacizumab 5 atezolizumab 4 Immunotherapy 4 CTLA-4 Antigen 4 trametinib 3 toripalimab 3 spartalizumab 3 dabrafenib 3 Temozolomide 3 Surgical Procedures, Operative 3 Standard of Care 3 Sodium Chloride 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04594187 2026-02-17

MelPORT

M.D. Anderson Cancer Center

Phase 2 Recruiting

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡